688799
vs
S
Shanghai Composite
688799
Over the past 12 months, Hunan Warrant Pharmaceutical Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +63% compared to the Shanghai Composite's +25% growth.
Stocks Performance
688799 vs Shanghai Composite
Performance Gap
688799 vs Shanghai Composite
Performance By Year
688799 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Hunan Warrant Pharmaceutical Co Ltd
Glance View
Hunan Warrant Pharmaceutical Co., Ltd. engages in the production of Chinese medicine. The company is headquartered in Changsha, Hunan and currently employs 1,103 full-time employees. The company went IPO on 2021-07-13. The firm's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The firm mainly conducts business within the domestic market.